Name: Healthcare Spotlight Series: AI and Analytics in Heart Health
Start: 2023-11-09T12:45:00-05:00
End: 2023-11-09T13:45:00-05:00
Location: Columbia Business School

Healthcare Spotlight Series: AI and Analytics in Heart Health

Healthcare and Pharmaceutical Management Program

Please join us for a Healthcare Spotlight Series event on the topic: Heart Health

Columbia Business School

<p>Cardiovascular disease (CVD) persists as a global challenge that profoundly impacts lives, economies, and healthcare systems. CVD is the leading cause of morbidity and mortality in the world, responsible for a third of all mortalities globally. In the United States, spending on cardiovascular disease and cardiovascular risk factors (cardiovascular spending) accounts for a significant portion of overall healthcare expenditures. From 2018-2019, the total cost of cardiovascular disease care in the U.S., including direct and indirect costs, was approximately $407 billion, or approximately 10.7% of total overall U.S. healthcare expenditures. The societal and economic burden of CVD has only risen since then, and its ripple effect extends far into outcomes impacting individual well-being, labor force productivity, and the economic growth of the nation.</p><p>There is a significant opportunity for innovation in heart health to augment the quality of cardiovascular disease care and overall outcomes. Digital innovation is a vital part of an accessible, efficient, and transformative healthcare system. When paired with investments in preventative and early-detection health solutions, it can significantly reduce the socioeconomic burden, boost productivity, and amplify health outcomes for all. <strong>Join us for a remarkable discussion with leaders in digital innovation in healthcare who will discuss the pivotal role that AI and analytics are playing in advancing healthcare, provide insights into how cutting-edge technologies are reshaping the future of cardiovascular disease, and share pathways future business leaders and investors can take as they identify new approaches to addressing significant issues for the U.S. healthcare system.</strong></p><p>Panelists:</p><ul><li>Ashley Beecy, MD, FACC, Medical Director of AI Operations at <strong>NewYork-Presbyterian Hospital</strong>, and Assistant Professor of Medicine, Division of Cardiology at <strong>Weill Cornell Medical College</strong></li><li>James K. Min, MD, FACC, FESC, MSCCT, Founder and CEO of <strong>Cleerly, Inc.</strong></li><li>Armen Vidian, Venture Capitalist with 10+ years of experience (now launching a new firm at the intersection of <strong>"deep tech" and healthcare</strong>)</li><li>(Moderator) Jing Dong, PhD, Regina Pitaro Associate Professor of Business at <strong>Columbia Business School</strong></li></ul>

<h1>Ashley Beecy, MD, FACC</h1><h3>Medical Director of AI Operations at <strong>NewYork-Presbyterian Hospital</strong>, and Assistant Professor of Medicine, Division of Cardiology at <strong>Weill Cornell Medical College</strong></h3><p>Dr. Ashley Beecy is the Medical Director of Artificial Intelligence (AI) Operations at NewYork-Presbyterian (NYP).  She is a core member of NYP’s AI leadership team partnering with clinical, administrative and research leaders across the enterprise to drive digital transformation and deliver on NYP’s data and AI strategy. Dr. Beecy provides leadership in key areas including the governance, processes, and infrastructure to ensure the responsible and agile deployment of AI. She is responsible for NYP’s largest enterprise-wide AI initiative in collaboration with Cornell Tech and Cornell University and serves as a subject matter expert on multiple national AI collaboratives.</p><p>Dr. Beecy is also an Assistant Professor of Medicine in the Division of Cardiology at Weill Cornell Medicine, where she leads the informatics work within the Division of Cardiology. She has a passion for taking a learning health system approach to improve healthcare delivery. Her research focus is on digital health and informatics, including the use of AI models for the detection and management of cardiovascular disease.</p><p>Dr. Beecy completed her undergraduate work in computer engineering. She holds a medical degree from Albert Einstein College of Medicine and completed an Internal Medicine residency at NewYork-Presbyterian/Weill Cornell Medicine. She completed her fellowship training in cardiovascular diseases at NewYork-Presbyterian/Weill Cornell Medicine. Prior to a career in healthcare, Dr. Beecy spent a decade working in industry. She has consulted for a range of healthcare companies and participated as a board member to advise on strategy and operations.</p>

<h1>James K. Min, MD, FACC</h1><h3>F﻿ounder and CEO, Cleerly, Inc.</h3><p>James K. Min, MD is a former Professor of Radiology and Medicine at Weill Cornell Medical College and the Director of the Dalio Institute of Cardiovascular Imaging (ICI) at NewYork-Presbyterian. He is a board-certified cardiologist with a clinical focus on cardiovascular disease prevention and cardiovascular imaging.</p><p>With a clinical and research focus on coronary artery disease, Min has published more than 500 peer-reviewed manuscripts that have been funded, in part, by numerous grants awarded by the National Institutes of Health and the Dalio Foundation. Min has served as Principal Investigator on numerous landmark multicenter clinical trials and registries, including the ACCURACY, CONFIRM, CONSERVE, CREDENCE, ICONIC and PARADIGM trials. Min is also the director of a state-of-the-art core laboratory for coronary computed tomography for several multicenter clinical trials, including for the PACIFIC and ISCHEMIA trials.</p><p>Min is Past President of the Society of Cardiovascular Computed Tomography (SCCT), where he served as Chair for the Annual Scientific Sessions meeting for 5 years. He was the 2017 recipient of the SCCT Gold Medal Award for lifetime achievement in the field of CT. He is a leader in the American College of Cardiology where he has served on the Task Force for Clinical Expert Consensus Documents and the Task Force for Appropriate Use Criteria. Min served as Editor-in-Chief of the Journal of Cardiovascular Computed Tomography, Associate Editor for the Journal of the American College of Cardiology: Cardiovascular Imaging, Associate Editor of the Journal of Nuclear Cardiology, and on the Editorial Board of Circulation: Cardiovascular Imaging. Min has received numerous awards and distinctions, including recently being inducted into the American Society of Clinical Investigation and the Academy of Radiology Research.</p><p>For Min, the development, validation and dissemination of Cleerly’s products and services offer him an opportunity to translate the large-scale clinical trial research he has spent doing in the last 17 years into daily clinical practice through innovative solutions in coronary heart disease that have not existed in the marketplace to date.</p><p>Min received his BA from the University of Chicago, and his medical degree from Temple University Medical School. He completed his internship, residency and cardiovascular medicine fellowship at the University of Chicago Hospitals.</p>

<h1>A﻿rmen Vidian</h1><h3>Venture Capitalist with 10+ years of experience (now launching a new firm at the intersection of <strong>"deep tech" and healthcare</strong>)</h3><p>Armen Vidian is a venture capitalist investing at the intersection of technology (“deep tech”), healthcare, and the life sciences. He was a Partner for 7 years at AI venture firm DCVC, where he played leadership roles in numerous investments, including Abcellera, Proprio, Caption Health, Recursion Pharmaceuticals, Strateos, Atomwise, and several others. Before venture capital, Armen was a hands-on operator for over two decades in the medical device industry, launching novel products globally. Realizing how data would influence clinical trials and medical products, Armen started a company, BlueTalon, which originally launched at the intersection of data and healthcare before its exit to Microsoft. Realizing that data and computation would forever change healthcare, he joined DCVC at the beginning of 2016 and began his career in venture capital, where he was well known for leveraging his operating experience in product and business development to guide early-stage entrepreneurs on their journey. He is currently creating something new in venture capital in the same space.</p>

<h1>Professor Jing Dong (Moderator)</h1><h3>Regina Pitaro Associate Professor of Business at <strong>Columbia Business School</strong></h3><p>Jing Dong is an Associate Professor in the Decision, Risk, and Operations division at the Graduate School of Business, Columbia University. Her primary research interests are in applied probability and stochastic simulation, with an emphasis on applications in service operations management. Her current research focuses on developing data-driven stochastic modeling to improve patient flow in hospitals.</p>

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Healthcare Spotlight Series: AI and Analytics in Heart Health

More events from Healthcare and Pharmaceutical Management Program

Follow organizers to get events picked for you

Healthcare Spotlight Series: AI and Analytics in Heart Health

More events from Healthcare and Pharmaceutical Management Program

Follow organizers to get events picked for you

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.